The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood
Open accessAbstract
Inter-individual DNA methylation variations were frequently hypothesized to alter individual susceptibility to Type 2 Diabetes Mellitus (T2DM). Sequence-influenced methylations were described in T2DM-associated genomic regions, but evidence for direct, sequence-independent association with disease risk is missing. Here, we explore disease-contributing DNA methylation through a stepwise study design: first, a pool-based, genome-scale screen among 1169 case and control individuals revealed an excess of differentially methylated sites in genomic regions that were previously associated with T2DM through genetic studies. Next, in-depth analyses were performed at selected top-ranking regions. A CpG site in the first intron of the FTO gene showed small (3.35%) but significant (P = 0.000021) hypomethylation of cases relative to controls. The effect was independent of the sequence polymorphism in the region and persists among individuals carrying the sequence-risk alleles. The odds of belonging to the T2DM group increased by 6.1% for every 1% decrease in methylation (OR = 1.061, 95% CI: 1.032-1.090), the odds ratio for decrease of 1 standard deviation of methylation (adjusted to gender) was 1.5856 (95% CI: 1.2824-1.9606) and the sensitivity (area under the curve = 0.638, 95% CI: 0.586-0.690; males = 0.675, females = 0.609) was better than that of the strongest known sequence variant. Furthermore, a prospective study in an independent population cohort revealed significant hypomethylation of young individuals that later progressed to T2DM, relative to the individuals who stayed healthy. Further genomic analysis revealed co-localization with gene enhancers and with binding sites for methylation-sensitive transcriptional regulators. The data showed that low methylation level at the analyzed sites is an early marker of T2DM and suggests a novel mechanism by which early-onset, inter-individual methylation variation at isolated non-promoter genomic sites predisposes to T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“False discovery rates associated with multiple hypothesis testing were estimated using the Benjamini and Hochberg procedure (44) or by q-values (45).”
MethodStatistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 1×
“False discovery rates associated with multiple hypothesis testing were estimated using the Benjamini and Hochberg procedure (44) or by q-values (45).”
MethodA map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877 · cited 2×
“8 (1000 Genomes Pilot 1) (40) encompassing an established T2D variant.”
BackgroundMethodHuman DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438 · cited 1×
“These frequencies are in accordance with the allelic distribution of rs1121980 in the Western European population (17), a population that is genetically related to the Ashkenazi Jews population.”
ResultGenome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Genome-Wide Mapping of in Vivo Protein-DNA Interactions
Johnson, D. S., Mortazavi, A., Myers, R. M., & Wold, B. (2007) · Science · doi:10.1126/science.1141319 · Cited by 2,927
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“DNA methylation levels are generally established early in development and are stably maintained thereafter (34).”
BackgroundTwelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Epigenome-wide association studies for common human diseases
Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3000 · Cited by 1,267
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells
Ball, M. P., Li, J. B., Gao, Y., Lee, J.-H., LeProust, E. M., Park, I.-H., Xie, B., Daley, G. Q., & Church, G. M. (2009) · Nature Biotechnology · doi:10.1038/nbt.1533 · Cited by 1,093
TRANSFAC: a database on transcription factors and their DNA binding sites
Wingender, E. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.238 · Cited by 1,054
Gene Body-Specific Methylation on the Active X Chromosome
Hellman, A., & Chess, A. (2007) · Science · doi:10.1126/science.1136352 · Cited by 729
Self-citationEpigenetics as a unifying principle in the aetiology of complex traits and diseases
Petronis, A. (2010) · Nature · doi:10.1038/nature09230 · Cited by 687
Watt, F., & Molloy, P. L. (1988) · Genes & Development · doi:10.1101/gad.2.9.1136 · Cited by 617
Methylation-Sensitive Sequence-Specific DNA Binding by the c-Myc Basic Region
Prendergast, G. C., & Ziff, E. B. (1991) · Science · doi:10.1126/science.1987636 · Cited by 579
Parental origin of sequence variants associated with complex diseases
DIAGRAM Consortium, Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher, S., Jonasdottir, A., Sigurdsson, A., Kristinsson, K. T., et al. (2009) · Nature · doi:10.1038/nature08625 · Cited by 553 · cited 1×
“In contrast to the previously reported sequence-directed methylations in T2DM (18,33), the methylation pattern described here is sequence-independent.”
ResultAn integrated epigenetic and genetic approach to common human disease
BJORNSSON, H. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.009 · Cited by 448
Kerkel, K., Spadola, A., Yuan, E., Kosek, J., Jiang, L., Hod, E., Li, K., Murty, V. V., Schupf, N., Vilain, E., et al. (2008) · Nature Genetics · doi:10.1038/ng.174 · Cited by 441
Replication timing-related and gene body-specific methylation of active human genes
Aran, D., Toperoff, G., Rosenberg, M., & Hellman, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq513 · Cited by 304
Self-citationLango, H., the U.K. Type 2 Diabetes Genetics Consortium, Palmer, C. N. A., Morris, A. D., Zeggini, E., Hattersley, A. T., McCarthy, M. I., Frayling, T. M., & Weedon, M. N. (2008) · Diabetes · doi:10.2337/db08-0504 · Cited by 294
Bell, C. G., Finer, S., Lindgren, C. M., Wilson, G. A., Rakyan, V. K., Teschendorff, A. E., Akan, P., Stupka, E., Down, T. A., Prokopenko, I., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014040 · Cited by 256
Type 2 diabetes: new genes, new understanding
Prokopenko, I., McCarthy, M. I., & Lindgren, C. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.09.004 · Cited by 254
A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin
Wong, R. H. F., Chang, I., Hudak, C. S. S., Hyun, S., Kwan, H.-Y., & Sul, H. S. (2009) · Cell · doi:10.1016/j.cell.2008.12.040 · Cited by 252
Allelic Skewing of DNA Methylation Is Widespread across the Genome
Schalkwyk, L. C., Meaburn, E. L., Smith, R., Dempster, E. L., Jeffries, A. R., Davies, M. N., Plomin, R., & Mill, J. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.01.014 · Cited by 244
Rohde, C., Zhang, Y., Reinhardt, R., & Jeltsch, A. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-230 · Cited by 238
CpG methylation as a mechanism for the regulation of E2F activity
Campanero, M. R., Armstrong, M. I., & Flemington, E. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100340697 · Cited by 230
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers
Sérandour, A. A., Avner, S., Percevault, F., Demay, F., Bizot, M., Lucchetti-Miganeh, C., Barloy-Hubler, F., Brown, M., Lupien, M., Métivier, R., et al. (2011) · Genome Research · doi:10.1101/gr.111534.110 · Cited by 226
Chromatin “Prepattern” and Histone Modifiers in a Fate Choice for Liver and Pancreas
Xu, C.-R., Cole, P. A., Meyers, D. J., Kormish, J., Dent, S., & Zaret, K. S. (2011) · Science · doi:10.1126/science.1202845 · Cited by 206
FTO, Type 2 Diabetes, and Weight Gain Throughout Adult Life
Hertel, J. K., Johansson, S., Sonestedt, E., Jonsson, A. E., Lie, R. T., Platou, C. G. P., Nilsson, P. M., Rukh, G., Midthjell, K., Hveem, K., et al. (2011) · Diabetes · doi:10.2337/db10-1340 · Cited by 150
Extensive sequence-influenced DNA methylation polymorphism in the human genome
Hellman, A., & Chess, A. J. (2010) · Epigenetics & Chromatin · doi:10.1186/1756-8935-3-11 · Cited by 138
Self-citationVallet, V. S., Casado, M., Henrion‐Caude, A., Bucchini, D., Raymondjean, M., Kahn, A., & Vaulont, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20175 · Cited by 131
Xu, J., Pope, S. D., Jazirehi, A. R., Attema, J. L., Papathanasiou, P., Watts, J. A., Zaret, K. S., Weissman, I. L., & Smale, S. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704579104 · Cited by 130
Bressler, J., Kao, W. H. L., Pankow, J. S., & Boerwinkle, E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010521 · Cited by 97
The nucleosome map of the mammalian liver
Li, Z., Schug, J., Tuteja, G., White, P., & Kaestner, K. H. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2060 · Cited by 91
Herder, C., Rathmann, W., Straßburger, K., Finner, H., Grallert, H., Huth, C., Meisinger, C., Gieger, C., Martin, S., Giani, G., et al. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1078730 · Cited by 71
Kark, J. D., Sinnreich, R., Leitersdorf, E., Friedlander, Y., Shpitzen, S., & Luc, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00408-6 · Cited by 57
Self-citationDocherty, S. J., Davis, O. S. P., Haworth, C. M. A., Plomin, R. J., & Mill, J. S. (2009) · Epigenetics & Chromatin · doi:10.1186/1756-8935-2-3 · Cited by 56
DNA methylation profiling using bisulfite-based epityping of pooled genomic DNA
Docherty, S. J., Davis, O. S. P., Haworth, C. M. A., Plomin, R. J., & Mill, J. S. (2010) · Methods · doi:10.1016/j.ymeth.2010.06.017 · Cited by 48
van Deursen, D., Jansen, H., & Verhoeven, A. J. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1125-6 · Cited by 34
Nyblom, H. K., Bugliani, M., Fung, E., Boggi, U., Zubarev, R., Marchetti, P., & Bergsten, P. (2009) · Journal of Proteome Research · doi:10.1021/pr9006816 · Cited by 33 · cited 1×
“Similar to USF1/2, MYCN and E2F family members bind their target sequences in a methylation-dependent manner (30,31), and might participate in T2DM-related pathways (32).”
BackgroundPlasma Homocysteine and Parental Myocardial Infarction in Young Adults in Jerusalem
Kark, J. D., Sinnreich, R., Rosenberg, I. H., Jacques, P. F., & Selhub, J. (2002) · Circulation · doi:10.1161/01.cir.0000017360.99531.26 · Cited by 31
Self-citationFriedlander, Y., Manor, O., Paltiel, O., Meiner, V., Sharon, N. A., Calderon‐Margalit, R., Hochner, H., Sagy, Y. W., Avgil, M., Harlap, S., et al. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.11.002 · Cited by 25
Self-citation
Cited by
Reinius, L. E., Acevedo, N., Joerink, M., Pershagen, G., Dahlén, S.-E., Greco, D., Söderhäll, C., Scheynius, A., & Kere, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041361 · Cited by 1,035
The bigger picture of FTO—the first GWAS-identified obesity gene
Loos, R. J. F., & Yeo, G. S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.227 · Cited by 723
Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004160 · Cited by 523
“However, recent studies have shown that modest differences in DNA methylation of individual CpG sites can have big effects on gene expression and that in late onset diseases such as T2D small changes in gene expression may have a big effect on disease over long periods of time [64].”
Chambers, J. C., Loh, M., Lehne, B., Drong, A., Kriebel, J., Motta, V., Wahl, S., Elliott, H. R., Rota, F., Scott, W. R., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00127-8 · Cited by 510
Touleimat, N., & Tost, J. (2012) · Epigenomics · doi:10.2217/epi.12.21 · Cited by 507
Metadata
- Authors
- Toperoff, G., Aran, D., Kark, J. D., Rosenberg, M., Dubnikov, T., Nissan, B., Wainstein, J., Friedlander, Y., Levy-Lahad, E., Glaser, B., & Hellman, A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-10-12
- Volume
- 21
- Issue
- 2
- Pages
- 371-383
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2103714979
- Cited by
- 349
- References
- 45
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.